首页> 外国专利> The crystal forms are 8s, 9s, 10R, 11S, 13s, 14s, 17r-11-hydroxi-17-2-hydroxietil-10, 13-dimetry-3-oxo-2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-tetratecahydro-1h-cyclop-afenantren-17-il Benzoato composite pharmacology, including the treatment of glaucoma and dry eye diseases.

The crystal forms are 8s, 9s, 10R, 11S, 13s, 14s, 17r-11-hydroxi-17-2-hydroxietil-10, 13-dimetry-3-oxo-2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-tetratecahydro-1h-cyclop-afenantren-17-il Benzoato composite pharmacology, including the treatment of glaucoma and dry eye diseases.

机译:晶体形式为8s,9s,10R,11S,13s,14s,17r-11-hydroxi-17-2-hydroxietil-10、13-dimetry-3-oxo-2、3、6、7、8、9, 10、11、12、13、14、15、16、17-四tecahydro-1h-cyclop-afenantren-17-il Benzoato复合药理学,包括治疗青光眼和干眼症。

摘要

POLYMORPHIC FORMS AND AMORPHAS OF BENZOATE 17-ALPHA CORTISOL PREPARATION METHOD PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND USE IN THE TREATMENT OF DRY EYE AND GLAUCOMA.
机译:苯甲酸酯17-α皮质醇制备方法的药理学组成和形态,包括它们及其在干眼和青光眼的治疗中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号